October 6, 2016—EpiPen manufacturer Mylan cheated Medicaid out of millions of dollars of drug rebates for almost 20 years by misclassifying the product as a generic, two senior members of Congress said yesterday after the Centers for Medicare & Medicaid Services confirmed the situation in a letter. Although CMS didn't address the matter in the letter, others in Congress … [Read more...]
Reputation Rehab Tip for Big Pharma: Stop Bashing 340B
October 5, 2016—Having infuriated Americans with sky-high drug prices, "you'd think the drug industry might look for ways to improve its image," writes former Congressman Gil Gutknecht (R-Minn.) in a commentary for Fortune.com. But if that's what you thought, he's quick to add, you'd be wrong. … [Read more...]
340B Is a Brake on Runaway Drug Prices
October 3, 2016—To clamp down on rising drug prices, Congress should protect the 340B drug discount program – a rare public policy initiative that helps healthcare providers and their patients, the leader of a group of more than 1,200 safety-net hospitals writes in a new op-ed for Yahoo Finance. … [Read more...]
Poll: 8 in 10 Americans Say Rx Drugs Cost Too Much
September 29, 2016—Nearly eight in 10 Americans (77 percent) think prescription drugs cost too much, the latest Kaiser Family Foundation tracking poll finds. The KKF poll adds to the growing body of evidence that Americans are fed up with drug company profiteering. The 340B drug discount program lowers drug prices for hospitals that care for large numbers of vulnerable … [Read more...]
Drugmakers to Multiple Sclerosis Group: Shut Up About Prices, or Else
September 28, 2016—The New York Times published a shocking article this morning about how drug companies tried to strong-arm a patient-advocacy group to keep quiet about obscenely high drug prices. As we've noted before, stories like these raise questions about what's motivating some disease-awareness groups to bad-mouth the 340B drug discount program. … [Read more...]
Bipartisan Bill Would Restore Rural Hospitals’ 340B Orphan Drug Discounts
September 27, 2016—A Democrat and Republican on the House Energy & Commerce Committee are co-sponsoring legislation to let rural hospitals get 340B drug discounts once again on orphan drugs when the drugs are used for non-orphan diseases or conditions. … [Read more...]
Poll: Americans Blame Drugmakers Most for High Healthcare Costs
September 23, 2016—Seventy percent of Americans think drug companies bear most of the blame for the high cost of healthcare, with health insurance companies coming in second (60 percent), a new survey shows. Forty three percent are very or somewhat worried about being unable to pay their medical bills in the coming year, with 31 percent citing out-of-pocket costs such as … [Read more...]